Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kitov Pharmaceuticals Holdings Ltd.

www.kitovpharma.com

Latest From Kitov Pharmaceuticals Holdings Ltd.

Pipeline Watch: Phase III Progress With Semaglutide, Tecentriq And Epidaza

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Deal Watch: BioLineRx, Ono, Vedantra Ink Separate Cancer Immunotherapy Pacts

BioLineRx buys Agalimmune and its alpha Gal candidate for melanoma and possibly other oncology indications. Japan's Ono signs an R&D agreement with Switzerland's Numab, while Boston biotechs Vedantra and Neon will collaborate on potential cancer vaccines.

Commercial Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Inflammation
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Kitov Pharmaceuticals Holdings Ltd.
  • Senior Management
  • Isaac Israel, CEO
    Simcha Rock, CFO
    John Paul Waymack, MD, Chmn. & CMO
    Gil Ben-Menachem, VP, Bus. Dev.
  • Contact Info
  • Kitov Pharmaceuticals Holdings Ltd.
    Phone: 2-625-4124
    132 Menachem Begin Rd., Round Tower
    Fl. 23
    Tel Aviv, 670110
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register